Outcomes and Tolerability of Chemoradiation Therapy for Pancreatic Cancer Patients Aged 75 Years or Older

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 4, 2010, Pages 1171-1177

  Miyamoto, David T ^a   Mamon, Harvey J ^b   Ryan, David P ^d   Willett, Christopher G ^c   Ancukiewicz, Marek ^d   Kobayashi, Wendy K ^d   Blaszkowsky, Lawrence ^d   Fernandez del Castillo, Carlos ^d   Hong, Theodore S ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemoradiation; Elderly; Pancreatic cancer; Radiation; Toxicity

Indexed keywords

ADVERSE EVENTS; CHEMORADIATION; CHEMORADIOTHERAPY; CONFIDENCE INTERVAL; DATA SETS; DISTANT METASTASIS; EASTERN COOPERATIVE ONCOLOGY GROUP; LOCAL RECURRENCE; OVERALL SURVIVAL; PANCREATIC CANCERS; RADIATION DOSE; RADIATION TOXICITY; RADIATION TREATMENTS; WEIGHT LOSS;

CHEMOTHERAPY; ONCOLOGY; TOXICITY;

RADIOTHERAPY;

CAPECITABINE; FLUOROURACIL; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; DEHYDRATION; DISTANT METASTASIS; EMERGENCY WARD; ESOPHAGITIS; FAILURE TO THRIVE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GERIATRIC DISORDER; HOSPITALIZATION; HUMAN; INFECTION; INTENSITY MODULATED RADIATION THERAPY; KIDNEY FAILURE; MALE; MEDICAL RECORD REVIEW; MENTAL HEALTH; MUCOSA INFLAMMATION; NAUSEA; OVERALL SURVIVAL; PAIN; PANCREAS CANCER; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING; WEIGHT REDUCTION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; COMORBIDITY; FAILURE TO THRIVE; FEMALE; HUMANS; MALE; NAUSEA; NEOPLASM STAGING; PAIN; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VOMITING;

EID: 77953588071     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.020     Document Type: Article

References (17)

1. Kalser M.H., and Ellenberg S.S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 (1985) 899-903
2. Klinkenbijl J.H., Jeekel J., Sahmoud T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230 (1999) 776-782 discussion 782-774
3. Garofalo M.C., Regine W.F., and Tan M.T. On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer. Ann Surg 244 (2006) 332-333 author reply 333
4. Moertel C.G., Frytak S., Hahn R.G., et al. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 48 (1981) 1705-1710
5. Klaassen D.J., MacIntyre J.M., Catton G.E., et al. Treatment of locally unresectable cancer of the stomach and pancreas: A randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil-an Eastern Cooperative Oncology Group study. J Clin Oncol 3 (1985) 373-378
6. Shinchi H., Takao S., Noma H., et al. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 53 (2002) 146-150
7. Krzyzanowska M.K., Weeks J.C., and Earle C.C. Treatment of locally advanced pancreatic cancer in the real world: Population-based practices and effectiveness. J Clin Oncol 21 (2003) 3409-3414
8. Sultana A., Tudur Smith C., Cunningham D., et al. Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. Br J Cancer 96 (2007) 1183-1190
9. Ries LAG MD, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute. Based on November 2007 SEER data submission, posted to the SEER Web site, 2008. http://seer.cancer.gov/csr/1975-2005/. Accessed Apr 2, 2009.
10. Piccirillo J.F., Tierney R.M., Costas I., et al. Prognostic importance of comorbidity in a hospital-based cancer registry. J Am Med Assoc 291 (2004) 2441-2447
11. Read W.L., Tierney R.M., Page N.C., et al. Differential prognostic impact of comorbidity. J Clin Oncol 22 (2004) 3099-3103
12. Neoptolemos J.P., Dunn J.A., Stocken D.D., et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial. Lancet 358 (2001) 1576-1585
13. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
14. Oettle H., Post S., Neuhaus P., et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. J Am Med Assoc 297 (2007) 267-277
15. Regine W.F., Winter K.A., Abrams R.A., et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial. J Am Med Assoc 299 (2008) 1019-1026
16. Bilimoria K.Y., Bentrem D.J., Ko C.Y., et al. National failure to operate on early stage pancreatic cancer. Ann Surg 246 (2007) 173-180
17. Krzyzanowska M.K., Earle C.C., Kuntz K.M., et al. Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 67 (2007) 211-218